Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance 15 January 2022 from 5 AM to 1 PM EST. Store functionality may be unavailable during this window.
We apologize for any inconvenience caused during this time.
Posted 05 June 2012 | By Louise Zornoza,
China's State Food and Drug Administration (SFDA) issued draft rules on 4 June that would require pharmaceutical manufacturers to establish a system of ensuring the quality of the excipients they use in their drug production.
The draft establishes drug manufacturers as having the primary responsibility to assure the quality of excipients obtained from suppliers
The goal of the draft rules is to "realize the full supervision of the pharmaceutical production and supply chain," SFDA said in a statement.
SFDA - Draft Rules on ExcipientsMore Breaking News from RegLink
Tags: Excipients, SFDA, pharmaceutical, cGMP, drug
Regulatory Focus newsletters
All the biggest regulatory news and happenings.